lysergic acid has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krisch, I; Milivojevic, N; Sket, D; Zivin, M | 1 |
Bean, JS; Bloomquist, WE; Cohen, ML; Kauffman, RF | 1 |
Benedict, CR; Pakala, R | 1 |
Glavan, G; Sket, D; Zivin, M | 1 |
4 other study(ies) available for lysergic acid and Disease Models, Animal
Article | Year |
---|---|
The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats.
Topics: Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Lysergic Acid; Male; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Self Administration | 2004 |
Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Cell Division; Disease Models, Animal; Heparin; Lysergic Acid; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Tunica Intima | 1993 |
Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cell Division; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Lysergic Acid; Male; Muscle, Smooth, Vascular; Pentanoic Acids; Platelet Aggregation; Pyridines; Rabbits; Serotonin; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase; Thymidine; Vasoconstrictor Agents | 1998 |
Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Corpus Striatum; Disease Models, Animal; Drug Interactions; Female; Gene Expression; Lysergic Acid; Neurotensin; Oxidopamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Tyrosine 3-Monooxygenase | 2002 |